RESECTABLE GASRTIC CANCER

Clinical trials for RESECTABLE GASRTIC CANCER explained in plain language.

Never miss a new study

Get alerted when new RESECTABLE GASRTIC CANCER trials appear

Sign up with your email to follow new studies for RESECTABLE GASRTIC CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Can adding immunotherapy to chemotherapy improve gastric cancer outcomes?

Disease control Not yet recruiting

This phase 2 trial is testing whether adding the immunotherapy drug durvalumab to standard chemotherapy (FLOT before surgery, TS-1 after) can improve outcomes for people with resectable gastric or gastroesophageal junction cancer. The study aims to see if this combination increas…

Matched conditions: RESECTABLE GASRTIC CANCER

Phase: PHASE2 • Sponsor: Taipei Veterans General Hospital, Taiwan • Aim: Disease control

Last updated Aug 13, 2026 00:00 UTC

RESECTABLE GASRTIC CANCER

Get alerted when new RESECTABLE GASRTIC CANCER trials appear

Can adding immunotherapy to chemotherapy improve gastric cancer outcomes?